In neurodegenerative disorders including Parkinson’s disease and multiple sclerosis, hyperactivation of PARP-1 results in neuronal death via accumulation of PAR polymers as well as excessive glial cell activation (Alano et al. 2010). This evidence concerns the gene PARP1 and Parkinson disease.